A study of the efficacy and safety of plaque psoriasis treatment by TNF‐α and IL‐17A inhibitor biologics in patients who received the inactivated SARS‐CoV‐2 vaccine

A study of the efficacy and safety of plaque psoriasis treatment by TNF‐α and IL‐17A inhibitor biologics in patients who received the inactivated SARS‐CoV‐2 vaccine

Abstract Background Vaccination is an important method for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission. There is currently a lack of real‐world clinical data regarding the safety and efficacy of coronavirus disease 2019 (COVID‐19) vaccines with respect...

Full description

Bibliographic Details
Main Authors: Shuhong Ye, Hong Sun, Zining Xu, Bingyang Xu, Na Wu, Jiawen Wu
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Immunity, Inflammation and Disease
Subjects:
biologics
inactivated SARS‐CoV‐2 vaccine
psoriasis
Online Access:https://doi.org/10.1002/iid3.938

Similar Items

Similar Items